DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Goldstein J, Elkind A, Keywood C. et al.
A low dose range-finding study of frovatriptan: a potent selective 5-HT1B/D agonist for the acute treatment of migraine.
Headache 1998; 38: 382-383
We do not assume any responsibility for the contents of the web pages of other providers.